Zusammenfassung
Ein Tumor, der aus proliferierenden malignen Spindelzellen besteht, die Osteoid oder Knochensubstanz produzieren.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Uribe-Botero G, Russell WO, Sutow WW, Martin RG (1977) Primary osteosarcoma of bone: a clinicopathologic investigation of 243 cases with necropsy studies in 54. Am J Clin Pathol 67: 4427–4435
Raymond AK, Chawla SP, Carrasco CH, Ayala AG, Fainning CV, Grice B, Armen T, Plager C, Papadopoulos NEJ, Edeiken J, Wallace S, Jaffe N, Murray JA, Benjamin RS (1987) Osteosarcoma chemotherapy effect: a prognostic factor. Sem Diag Path 4: 212–313
Ayala AG, Ro JY, Fanning CV, Carrasco CH (1990) Needle biopsy of bone lessions. Cancer Bull 42: 305–313
Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of muscopuloskeletal sarcoma. Clin Orthop 153: 106–120
Taylor WF, Ivins JC, Unni KK, Beabout JW, Golenzer HJ, Black LE (1989) Prognostic variables in osteosarcoma: a multiinstitutional study. J Natl Cancer Inst 81: 21–30
Grem JL, King SA, Wittes RE, Leyland-Jones B (1988) The role of methotrexate in osteosarcoma. J Natl Cancer Inst 80: 626–655
Cortes EP, Holland JF, Wang JJ, Sinks LF (1973) Chemotherapy of advanced osteosarcoma, Bone: certain aspects of neoplasia; proceedings of the 24th symposium of the Colston Research Society (eds Price and Ross). Butterworths, London, pp 265–280
Jaffe N (1983) Progress in the treatment of osteosarcoma. Clinical Cancer Briefs 5: 3–13
Rosen G, Caparros B, Nirenberg A, Juergens H, Huvos AG (1980) The successful management of metastatic osteogenic sarcoma: a model for the treatment of primary osteogenic sarcoma. Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas (ed van Oosterom AT et al.). Martinus Nijhoff Publishers, The Hague Boston London, pp 349–366
Mavligit GM, Benjamin R, Patt YZ, Jaffe N, Cuang V, Wallace S, Murray J, Ayala A, Johnston S, Hersh EM, Calvo II DB (1981) Intraarterial cisplatinum for patients with inoperable skeletal tumors. Cancer 48: 1–4
Marti C, Kroner T, Remagan W, Berchthold W, Cserhati M, Varini M (1985) High-dose ifosfamide in advanced osteosarcoma. Cancer Treat Rep 69: 115–117
Benjamin RS, Baker LH, O’Bryan RM, Moon TE, Gottlieb JA (1978) Chemotherapy for metastatic osteosarcma–studies by the MD Anderson Hospital and the Southwest Oncology Group. Cancer Treat Rep 62: 237–238
Pratt CB, Meyer WH (1987) Response to chemotherapy of patients with metastatic or unresectable osteosarcoma at diagnosis and after failing adjuvant chemotherapy. Proc Am Soc Clin Oncol 6: 214
Morgan E, Baum E, Bleyer A, Movassaghi N, Provisor A, Lampkin B, Lukens S, Sather H, Hammond D (1981) Treatment of relapsed osteogenic sarcoma in children. Proc Am Assoc Cancer Res 22: 399
Mosende C, Gutierrez M, Caparros B, Rosen G (1977) Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma. Cancer 40: 2779–2786
Cortes EP, Holland JF, Glidewell 0 (1978) Amputation and adriamycin in primary osteosarcoma: a 5-year report. Cancer Treat Rep 62: 271–277
Ryan J, Baker L, Benjamin R, Murphy W, Balcerzak S, Gottlieb J (1990) Long term follow up in the cure of osteogenic sarcoma. Chir Organi Mov LXXV: 48–48
Bleyer WA, Haas JE, Feigl P, Greenlee TK, Schaller RT, Morgan A, Pendergrass TW, Johnson FL, Dernstein ID, Chard RL, Hartman (1982) Improved three-year disease-free survival in osteogenic sarcoma. J Bone and Joint Surgery 64-B: 233–238
Winkler K, Beron G, Schellong G, Stollmann B, Prindull G, Lasson U, Brandeis W, Henze G, Ritter J, Russe W, Stengel-Rutkowski L, Treuner J, Landbeck G (1982) Cooperative osteosarcoma study COSS-77: results after more than 4 years. Klin Paediatr 194: 251–256
Edmonson JH, Green SJ, Ivins JC, Gilchrist GS, Creagan ET, Pritchard DJ, Smithson WA, Dahlin DC, Taylor WF (1984) A controlled pilot study of highdose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 2: 152–156
Eilber F, Giuliano A, Eckhardt J, Patterson K, Mosely S, Goodnight J (1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5: 21–26
Link MP, Goorin AM, Miser AW, Green M, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA, Ayala AG, Shuster JJ, Abelson HT, Simone JV, Vietti TJ (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314: 1600–1602
Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221–1230
Saeter G, Alvegard A, Elomaa I, Stenwig AE, Holmström T, Solheim OP (1991) Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A scandinavian sarcoma group study. J Clin Oncol 9: 1766–1775
Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfürst C, Berger J, Ritter J, Jürgens H, Gerein V, Graf N, Russe W, Gruemayer ER, Ertelt W, Kotz R, Preusser P, Prindull G, Brandeis W, Landbeck G (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6: 329–337
Jaffe N, Raymond AK, Ayala A Carrasco CH, Wallace S, Robertson R, Griffiths M, Wang Y-M (1987) Effect of escalating courses of intraarterial cis-diamminedichlorplatinum-II on the primary tumor in pediatric osteosarcoma. Proc Am Soc Clin Oncol 6: 217
Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Jürgens H, Ritter J, Kusnierz-Glaz C, Erttmann R, Gädicke G, Graf N, Ladenstein R, Leyvraz S, Mertens R, Weinel P (1990) Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 66: 1703–1710
Bacci G, Picci P, Gherlinzoni F, Horn JR van, Orlandi M, Normand R, Manfrini M, Pignatti G, Campanacci M (1986) Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Chemioterapia 5: 140–143
Benjamin RS, Chawla SP, Carrasco CH, Raymond AK, Murray JA, Armen TO, Wallace S, Ayala A, Papadopoulos NEJ, Plager C, Romsdahl MM, Martin RG (1990) Primary chemotherapy for osteosarcoma with systemic adriamycin and intra-arterial cisplatin. Cancer Bull 42: 314–317
Bramwell VHC, Burgers M, Sneath R, Souhami R, Oosterom AT van, Voute PA, Rouesse J, Spooner D, Craft AW, Somers R, Pringle J, Malcolm AJ, Eijken J, Thomas D, Uscinska B, Machin D, Glabbeke M van (1992) A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup. J Clin Oncol 10: 1579–1591
Salem PA, Benjamin RS, Howard J, Gutterman JU (1991) Phase II trial of recombination interferon alpha 2-b in the treatment of advanced metastatic and refractory sarcoma. Proc Am Assoc Cancer Res 32: 200
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Patel, S.R., Benjamin, R.S. (1993). Osteosarkom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-662-10495-8_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56872-8
Online ISBN: 978-3-662-10495-8
eBook Packages: Springer Book Archive